before and after tirzepatide side effects ✨ GLP-1 & After: A Transformation ✨ This patient has been on a steady weight loss journey, shedding 78 pounds over the past two years with the help of Tirzepatide ✨ Before & After Transformation

Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, has received MHRA marketing authorisation

Starting mid-2026, Medicare will cover injectable weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound for eligible individuals with severe obesity or related health conditions, at a cost of $245 per month to Medicare and a maximum $50 monthly copay for recipients

Talk to your healthcare provider about how you can take part in this registry or you may contact Novo Nordisk at 1-877-390-2760

And in the MCAS case series, most patients who stopped their GLP-1RA (whether due to cost, unavailability, or curiosity about what would happen) experienced a return of the symptoms that had been controlled

Similarly, the dropout rate from ketogenic diets compared to control diets requires further investigation, as it varies significantly across studies, ranging from 13% to 84% [261]

South Carolina is home to several highways known for high accident and fatality rates, putting drivers at increased risk of serious personal injury or death